Telix Pharmaceuticals Ltd. has entered an agreement to acquire radioisotope production technology firm ARTMS Inc., its advanced cyclotron-based isotope production platform, manufacturing plant and stockpile of ultra-pure rare metals required for consumable target production.   ARTMS, based in Burnaby, British Columbia, Canada, is a privately held, venture-backed company, which specializes in the physics, chemistry and materials science of cyclotron-produced radionuclides. A spin-out company fr...